BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 22399192)

  • 1. Loss of enteric neuronal Ndrg4 promotes colorectal cancer via increased release of Nid1 and Fbln2.
    Vaes N; Schonkeren SL; Rademakers G; Holland AM; Koch A; Gijbels MJ; Keulers TG; de Wit M; Moonen L; Van der Meer JRM; van den Boezem E; Wolfs TGAM; Threadgill DW; Demmers J; Fijneman RJA; Jimenez CR; Vanden Berghe P; Smits KM; Rouschop KMA; Boesmans W; Hofstra RMW; Melotte V
    EMBO Rep; 2021 Jun; 22(6):e51913. PubMed ID: 33890711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients.
    Jandrey EHF; Moura RP; Andrade LNS; Machado CL; Campesato LF; Leite KRM; Inoue LT; Asprino PF; da Silva APM; de Barros ACSD; Carvalho A; de Lima VC; Carraro DM; Brentani HP; da Cunha IW; Soares FA; Parmigiani RB; Chammas R; Camargo AA; Costa ÉT
    NPJ Breast Cancer; 2019; 5():11. PubMed ID: 30963110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A composite network of conserved and tissue specific gene interactions reveals possible genetic interactions in glioma.
    Voigt A; Nowick K; Almaas E
    PLoS Comput Biol; 2017 Sep; 13(9):e1005739. PubMed ID: 28957313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics.
    Teunissen CE; Elias N; Koel-Simmelink MJ; Durieux-Lu S; Malekzadeh A; Pham TV; Piersma SR; Beccari T; Meeter LH; Dopper EG; van Swieten JC; Jimenez CR; Pijnenburg YA
    Alzheimers Dement (Amst); 2016; 2():86-94. PubMed ID: 27239539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine Expression of NDRG4 Is Induced by Estrogen and Up-Regulated during Embryo Implantation Process in Mice.
    Yang Q; Gu Y; Zhang X; Wang JM; He YP; Shi Y; Sun ZG; Shi HJ; Wang J
    PLoS One; 2016; 11(5):e0155491. PubMed ID: 27175791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NDRG4, a novel candidate tumor suppressor, is a predictor of overall survival of colorectal cancer patients.
    Chu D; Zhang Z; Zhou Y; Li Y; Zhu S; Zhang J; Zhao Q; Ji G; Wang W; Zheng J
    Oncotarget; 2015 Apr; 6(10):7584-96. PubMed ID: 25749388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic reg IV is a novel prognostic marker for glioma patient survival.
    Wang Q; Deng J; Yuan J; Wang L; Zhao Z; He S; Zhang Y; Tu Y
    Diagn Pathol; 2012 Jun; 7():69. PubMed ID: 22713481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
    Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
    Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stratifin expression is a novel prognostic factor in human gliomas.
    Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z
    Pathol Res Pract; 2011 Nov; 207(11):674-9. PubMed ID: 21940111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nervous NDRGs: the N-myc downstream-regulated gene family in the central and peripheral nervous system.
    Schonkeren SL; Massen M; van der Horst R; Koch A; Vaes N; Melotte V
    Neurogenetics; 2019 Oct; 20(4):173-186. PubMed ID: 31485792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of N-Myc downstream-regulated gene 4 influences patient survival in gliomas.
    Li S; Yang B; Li G; He S; Li Y
    Brain Tumor Pathol; 2013 Jan; 30(1):8-14. PubMed ID: 22399192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.
    Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Gao G; Zhang Y
    J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma.
    He S; Deng J; Li G; Wang B; Cao Y; Tu Y
    Jpn J Clin Oncol; 2012 Mar; 42(3):196-201. PubMed ID: 22217575
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.